¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Mutation, acquired"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
allelic mutation
¸Â¼¶µ¹¿¬º¯ÀÌ, ´ë¸³µ¹¿¬º¯ÀÌ
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
cold-sensitive mutation
Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ, Àú¿Â°¨¼ö¼ºµ¹¿¬º¯ÀÌ
conditional lethal mutation
Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
conditional mutation
Á¶°Çµ¹¿¬º¯ÀÌ
chromosomal mutation
¿°»öüµ¹¿¬º¯ÀÌ
chromosome mutation
¿°»öüµ¹¿¬º¯ÀÌ
drift mutation
¿¬¼Óº¯ÀÌ
dominant mutation
¿ì¼ºµ¹¿¬º¯ÀÌ
extragenic suppressor mutation
À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
forward mutation
¾ÕÂʵ¹¿¬º¯ÀÌ, ÀüÇâµ¹¿¬º¯ÀÌ
frameshift mutation
ƲÀ̵¿µ¹¿¬º¯ÀÌ
genetic mutation
À¯Àüµ¹¿¬º¯ÀÌ
genomic mutation
À¯Àüüµ¹¿¬º¯ÀÌ
induced mutation
À¯¹ßµ¹¿¬º¯ÀÌ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
hospital acquired infection
¿ø³»°¨¿°, º´¿ø°¨¿°
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
chromosomal mutation
¿°»öüº¯ÀÌ, ¿°»öüµ¹¿¬º¯ÀÌ
cold-sensitive mutation
Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ
conditional mutation
Á¶°Çµ¹¿¬º¯ÀÌ
conditional lethal mutation
Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
dominant mutation
¿ì¼ºµ¹¿¬º¯ÀÌ
drift mutation
¿¬¼Óº¯ÀÌ
mutation detection
µ¹¿¬º¯À̰ËÃâ
extragenic suppressor mutation
À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
forward mutation
ÀüÇâµ¹¿¬º¯ÀÌ
frequency mutation
µ¹¿¬º¯À̺óµµ
genetic mutation
À¯Àüµ¹¿¬º¯ÀÌ
genomic mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ, À¯Àüüµ¹¿¬º¯ÀÌ
mutation genetics
º¯ÀÌÀ¯ÀüÇÐ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acquired blindness
ÈÄõ¸Í.
acquired character
ÈÄõÇüÁú(¡û¡òõ).
acquired color vision defect
ÈÄõ»ö°¢ÀÌ»ó
acquired cystic disease of the kidney
ÈÄõ¼º ½Å³¶Æ÷Áúȯ
acquired deafness
ÈÄõ(¼º) ³Ã» ³ó
acquired digital fibrokeratoma
ÈÄõ¼º ¼Õ¹ß°¡¶ô ¼¶À¯ °¢ÈÁ¾
acquired disease
ÈÄõ¼º Áúº´(¡òðÜ»).
acquired heart disease =AHD
ÈÄõ¼º ½ÉÁúȯ(¡ãýòðü´).
acquired hyperoxaluria
ÈÄõ¼º °í¼ö»ê´¢Áõ
acquired ichthyosis
ÈÄõ¼º(ýô¸àõ)¾î¸°¼±(åà×÷àÈ)
acquired immune deficiency
ÈÄõ¼º ¸é¿ª°áÇÌ
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
acquired immunity
ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
acquired immunodeficiency syndorme
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
acquired immunity
ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
acquired immunodeficiency syndorme
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
acquired immunodeficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired immunodeficiency syndrome
ÈÄõ¼º¸é¿ª°áÇÌÁõ
acquired immunodeficiency syndrome (AIDS)
ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
acquired immunodeficiency syndrome(AIDS)
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired perforating dermatosis
ÈÄõ¼º õ°ø¼º ÇǺκ´
acquired porphyria cutanea tarda
ÈÄõ¼º Áö¿¬¼º ÇǺΠÆ÷¸£ÇǸ°Áõ(~ñø)
acquired progressive lymphangioma
ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
acquired reactive perforating dermatosis
ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
acquired resistence
ȹµæÀúÇ×¼º(¡î½ù÷àõ).
acquired tolerance
ȹµæ°ü¿ë, ÈÄõ¼º°ü¿ë
acquired tolerance
ÈÄõ(¼º) ³»¼º(¡Ò±àõ), ȹµæ°ü¿ë.
aids=£¾acquired immune deficiency syndrome
ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ýô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½